Congress Squares Off Over Drug Pricing And A Controversial Drug Discount Program
(By Sarah Jane Tribble for Kaiser Health News) House Democrats are calling foul on Republican assertions that cuts to a
Read More(By Sarah Jane Tribble for Kaiser Health News) House Democrats are calling foul on Republican assertions that cuts to a
Read MoreIn Kimberly Lankford’s column she answers a reader’s question on when to sign up for Medicare supplement, Medicare Part D
Read More(By Brian Zimmerman for Becker’s Hospital Review) Just 47 percent of Americans think opioid addiction is treatable, according to preliminary
Read More(By Ayla Ellison for Becker’s Hospital Review) CMS has released its 2018 Medicare Outpatient Prospective Payment System proposed rule, which
Read More(By David Armstrong for STAT) Federal law enforcement agencies announced Thursday what they called “the largest opioid-related fraud takedown in
Read More(By Charles Ornstein for NPR and produced by ProPublica) In Washington, D.C., a Medicare beneficiary filled prescriptions for 2,330 pills
Read More(By Adam Feuerstein and Damian Garde for STAT) Novartis’ groundbreaking CAR-T cancer therapy is one big step closer to reaching
Read More(By Brian Zimmerman for Becker’s Hospital Review) The U.S. Food and Drug Administration on July 5 issued a warning letter
Read More(By Damian Garde and Adam Feurerstein for STAT) The FDA has weighed in on Novartis’ pioneering personalized cancer therapy, which
Read More(By David Armstrong for STAT and Evan Allen for Boston Globe) Drug users, desperate to break addictions to heroin or
Read More